Avadel Pharmaceuticals Plc Stock Investor Sentiment

AVDL Stock  USD 15.83  0.42  2.58%   
About 54% of Avadel Pharmaceuticals' institutional investors are presently thinking to get in. The analysis of overall sentiment of trading Avadel Pharmaceuticals PLC stock suggests that some investors are interested at this time. Avadel Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Avadel Pharmaceuticals PLC. The current market sentiment, together with Avadel Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Avadel Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.

Panic Vs Confidence

54

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Avadel Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Avadel Pharmaceuticals PLC.
Avadel Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Avadel daily returns and investor perception about the current price of Avadel Pharmaceuticals PLC as well as its diversification or hedging effects on your existing portfolios.

Avadel Historical Sentiment

Although Avadel Pharmaceuticals' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Avadel, such as negative comments on social media and news outlets, may cause fear in the market and push Avadel Pharmaceuticals' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Avadel.
  

Avadel Pharmaceuticals Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Avadel Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Avadel Pharmaceuticals Historical Investor Sentiment

Investor biases related to Avadel Pharmaceuticals' public news can be used to forecast risks associated with an investment in Avadel. The trend in average sentiment can be used to explain how an investor holding Avadel can time the market purely based on public headlines and social activities around Avadel Pharmaceuticals PLC. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Avadel Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Avadel Pharmaceuticals and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Avadel Pharmaceuticals news discussions. The higher the estimate score, the more favorable the investor's outlook on Avadel Pharmaceuticals.
a day ago at insidermonkey.com         
Avadel Pharmaceuticals plc Q1 2024 Earnings Call Transcript
insidermonkey News
2 days ago at gurufocus.com         
Avadel Pharmaceuticals Reports First Quarter 2024 Earnings Revenue Surpasses Estimates but Net ...
Gurufocus Stories at Macroaxis
2 days ago at investorplace.com         
AVDL Stock Earnings Avadel Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024
sbwire news
3 days ago at seekingalpha.com         
Avadel Pharmaceuticals plc Q1 2024 Earnings Preview
seekingalpha News
few days ago at news.google.com         
Investing in Avadel Pharmaceuticals five years ago would have delivered you a 182 percent gain - Yah...
Google News at Macroaxis
six days ago at news.google.com         
Bullish Avadel Pharmaceuticals plc insiders were rewarded last week as their US1.2m investment ... -...
Google News at Macroaxis
over a week ago at news.google.com         
Avadel Pharmaceuticals to Release Quarterly Earnings on Wednesday - MarketBeat
Google News at Macroaxis
over a week ago at finance.yahoo.com         
Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results...
Yahoo News
over a week ago at www.macroaxis.com         
Disposition of 125000 shares by Jerad Seurer of Avadel Pharmaceuticals at 13.57 subject to Rule 16b-...
Macroaxis News
over a week ago at zacks.com         
Wall Street Analysts Predict a 28.58 percent Upside in Avadel Heres What You Should Know
zacks News
over a week ago at finance.yahoo.com         
Wall Street Analysts Predict a 28.58 percent Upside in Avadel Heres What You Should Know
Yahoo News
over two weeks ago at news.google.com         
Analysts Set Avadel Pharmaceuticals plc PT at 22.57 - MarketBeat
Google News at Macroaxis
over two weeks ago at news.google.com         
106,475 Shares in Avadel Pharmaceuticals plc Purchased by Investors Asset Management of ... - Market...
Google News at Macroaxis
over three weeks ago at news.google.com         
Avadel Pharmaceuticals Shares Down 3.4 percent - MarketBeat
Google News at Macroaxis
over three weeks ago at news.google.com         
Avadel Pharmaceuticals Sees Unusually Large Options Volume - MarketBeat
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Avadel Pharmaceuticals that are available to investors today. That information is available publicly through Avadel media outlets and privately through word of mouth or via Avadel internal channels. However, regardless of the origin, that massive amount of Avadel data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Avadel Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Avadel Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Avadel Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Avadel Pharmaceuticals alpha.

Avadel Pharmaceuticals Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
Avadel Pharmaceuticals Analysts Increase Their Forecasts After Q4 Results
03/05/2024
2
Investment Report - Stock Traders Daily
03/20/2024
3
Avadel Stock A Deep Dive Into Lumryzs Once-Nightly Revolution - Seeking Alpha
04/02/2024
4
Avadel Pharmaceuticals plc Is Expected To Breakeven In The Near Future
04/11/2024
5
Avadel Pharmaceuticals Trading 5.9 percent Higher - MarketBeat
04/15/2024
6
106,475 Shares in Avadel Pharmaceuticals plc Purchased by Investors Asset Management of ... - MarketBeat
04/18/2024
7
Wall Street Analysts Predict a 28.58 percent Upside in Avadel Heres What You Should Know
04/29/2024
8
Disposition of 125000 shares by Jerad Seurer of Avadel Pharmaceuticals at 13.57 subject to Rule 16b-3
04/30/2024
9
Avadel Pharmaceuticals to Release Quarterly Earnings on Wednesday - MarketBeat
05/02/2024
10
Avadel Pharmaceuticals plc Q1 2024 Earnings Preview
05/07/2024
11
Avadel Pharmaceuticals plc Q1 2024 Earnings Call Transcript
05/09/2024
When determining whether Avadel Pharmaceuticals is a strong investment it is important to analyze Avadel Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avadel Pharmaceuticals' future performance. For an informed investment choice regarding Avadel Stock, refer to the following important reports:
Check out Avadel Pharmaceuticals Hype Analysis, Avadel Pharmaceuticals Correlation and Avadel Pharmaceuticals Performance.
Note that the Avadel Pharmaceuticals information on this page should be used as a complementary analysis to other Avadel Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Avadel Stock analysis

When running Avadel Pharmaceuticals' price analysis, check to measure Avadel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avadel Pharmaceuticals is operating at the current time. Most of Avadel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Avadel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avadel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Avadel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Commodity Directory
Find actively traded commodities issued by global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Is Avadel Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.00)
Revenue Per Share
0.349
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.58)
Return On Equity
(4.81)
The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.